The Medical Imaging Center of the University Medical Center Groningen, consisting of the Departments of Nuclear Medicine & Molecular Imaging and Radiology, cordially invites you to join the International Symposium “Molecular Imaging Agents in Medicine” to be held in Groningen, the Netherlands, on February 13th to 15th, 2017 and the Post Congress “Photopharmacology” on FebruaryRead more →
The paper on the clinical phase I study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published online at the website of Clinical Cancer Research: http://clincancerres.aacrjournals.org/content/early/2016/11/09/1078-0432.CCR-16-0437. The study was funded by CTMM MAMMOTH project and the ERC OnQView grant The study was executed at the University Medical Center Groningen and University Medical Center Utrecht Tumor-specificRead more →
Two posters accepted at San Antonio Breast Cancer Conference 2016 Validation of a Chinese nomogram with a Dutch breast cancer population: Excellent prediction of the probability of axillary lymph node metastasis Presentation by: Siqi Qiu MARGIN-I study: Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery inRead more →
We are pleased to inform you that the review called ‘Emerging Targets in Photopharmacology’ is published online at the website of the Angewandte Chemie international edition. The paper can be found here.Read more →
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. The Lancet Gastroenterology & Hepatology. doi: 10.1016/S2468-1253(16)30082-6. Epub 2016 September 17.
Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. Eur J Pharm Biopharm. 2016 Jul;104:226-34. doi: 10.1016/j.ejpb.2016.05.008. Epub 2016 May 12. PMID: 27179587